Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz
July 09, 2015 at 08:56 AM EDT
In a report published Wednesday, Barclays analyst Douglas Tsao detailed why he believes that M&A activity within the Specialty ...